Literature DB >> 10617588

Olf-1, a neuron-specific transcription factor, can activate the herpes simplex virus type 1-infected cell protein 0 promoter.

L R Devireddy1, C J Jones.   

Abstract

Herpes simplex virus type 1 (HSV-1) establishes a life-long latent infection in sensory neurons of infected individuals. Infected cell protein 0 (ICP0) is important for productive infection and reactivation from latency. Thus, activation of ICP0 expression in neurons is likely to be important for reactivation from latency. In a mouse neuroblastoma cell line, ICP0 promoter activity is high compared with other strong viral promoters. In contrast, promoter activity is low in non-neuronal cells. DNase I footprinting assays indicated that three distinct motifs in the ICP0 promoter are bound by nuclear factors. One of these motifs contains a binding site for a novel helix-loop-helix olfactory neuron-specific transcription factor (Olf-1). Gel shift assays and supershift assays using an Olf-1-specific antibody demonstrated that mouse neuroblastoma cells express Olf-1, which is bound to the Olf-1-like site in the ICP0 promoter. Deletion of the putative Olf-1 motif reduced ICP0 promoter activity more than 5-fold in mouse neuroblastoma cells and prevented trans-activation by an Olf-1 expression vector. We hypothesize that the Olf-1-binding site activates ICP0 promoter activity in neurons during reactivation from latency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10617588     DOI: 10.1074/jbc.275.1.77

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Analysis of herpes simplex virus ICP0 promoter function in sensory neurons during acute infection, establishment of latency, and reactivation in vivo.

Authors:  R L Thompson; May T Shieh; N M Sawtell
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 2.  Olfactory transmission of neurotropic viruses.

Authors:  Isamu Mori; Yukihiro Nishiyama; Takashi Yokochi; Yoshinobu Kimura
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

3.  Region of herpes simplex virus type 1 latency-associated transcript sufficient for wild-type spontaneous reactivation promotes cell survival in tissue culture.

Authors:  M Inman; G C Perng; G Henderson; H Ghiasi; A B Nesburn; S L Wechsler; C Jones
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Neurons differentially activate the herpes simplex virus type 1 immediate-early gene ICP0 and ICP27 promoters in transgenic mice.

Authors:  Christie M Loiacono; Robert Myers; William J Mitchell
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle.

Authors:  Guey-Chuen Perng; Clinton Jones
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-15

6.  Role of nuclear factor Y in stress-induced activation of the herpes simplex virus type 1 ICP0 promoter.

Authors:  Anna S Kushnir; David J Davido; Priscilla A Schaffer
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

7.  Cloning and initial characterization of an alternatively spliced transcript encoded by the bovine herpes virus 1 latency-related gene.

Authors:  Laxminarayana R Devireddy; Yange Zhang; Clinton J Jones
Journal:  J Neurovirol       Date:  2003-12       Impact factor: 2.643

Review 8.  Herpes simplex virus type 1 and bovine herpesvirus 1 latency.

Authors:  Clinton Jones
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

9.  Herpesvirus quiescence in neuronal cells. V: forskolin-responsiveness of the herpes simplex virus type 1 alpha0 promoter and contribution of the putative cAMP response element.

Authors:  Robert J Danaher; Robert J Jacob; Craig S Miller
Journal:  J Neurovirol       Date:  2003-08       Impact factor: 2.643

10.  Early B-cell Factor gene association with multiple sclerosis in the Spanish population.

Authors:  Alfonso Martínez; Ana Mas; Virginia de las Heras; Rafael Arroyo; Miguel Fernández-Arquero; Emilio G de la Concha; Elena Urcelay
Journal:  BMC Neurol       Date:  2005-10-28       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.